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Many nutritional interventions that increase lifespan are also proposed to postpone
age-related declines in motor and cognitive function. Potential sources of anti-aging
compounds are the plants and fungi that have adapted to extreme environments. We
studied the effects of four commonly consumed and culturally relevant Interior Alaska
berry and fungus species (bog blueberry, lowbush cranberry, crowberry, and chaga) on
the decline in overall health and neuron function and changes in touch receptor neuron
morphology associated with aging. We observed increased wild-type Caenorhabditis
elegans lifespan and improved markers of healthspan upon treatment with Alaskan
blueberry, lowbush cranberry, and chaga extracts. Interestingly, although all three
treatments increased lifespan, they differentially affected the development of aberrant
morphologies in touch receptor neurons. Blueberry treatments decreased anterior
mechanosensory neuron (ALM) aberrations (i.e., extended outgrowths and abnormal cell
bodies) while lowbush cranberry treatment increased posterior mechanosensory neuron
(PLM) aberrations, namely process branching. Chaga treatment both decreased ALM
aberrations (i.e., extended outgrowths) and increased PLM aberrations (i.e., process
branching and loops). These results support the large body of knowledge positing that
there are multiple cellular strategies and mechanisms for promoting health with age.
Importantly, these results also demonstrate that although an accumulation of abnormal
neuron morphologies is associated with aging and decreased health, not all of these
morphologies are detrimental to neuronal and organismal health.
Keywords: mechanosensory neuron, C. elegans neuron aging, neuron morphology, nutrition, blueberry, lowbush
cranberry, chaga, crowberry
INTRODUCTION
Aging is a ubiquitous process affecting the health of increasing numbers of aged individuals
throughout the world. Gradual declines in many physiological functions accompany increased
chronological age and are associated with increased mortality. Thus, development of strategies
to improve tissue, system, and organismal function during aging is an increasing public health
priority. Alaskan traditional ecological knowledge holds that a diverse array of local berries, plants,
Frontiers in Aging Neuroscience | www.frontiersin.org 1 July 2016 | Volume 8 | Article 173
fnagi-08-00173 July 14, 2016 Time: 14:13 # 2
Scerbak et al. Mechanosensory Neuron Aging and Alaskan Nutraceuticals
and fungi benefit health and wellness. While plant matter consists
of a low proportion of total energy intake in traditional Alaska
Native diets (<3% compared to 90% from fish and game meat
and fat; Bersamin et al., 2007), plants and fungi historically were
and currently are highly valued by Alaska Native traditional
healers (Loring and Gerlach, 2009). Various berries, plant greens,
and fungi are consumed as part of a standard subsistence diet
and used by traditional healers and contemporary herbalists to
combat health problems ranging from stomach and muscle pain
to bleeding and snow blindness. An increasing number of studies
show that transitioning away from Alaska Native traditional
diets and lifestyles is associated with increased incidence of age-
associated disorders, including cardiovascular disease (Ebbesson
et al., 2005; Loring and Gerlach, 2009). Importantly, cultures
throughout the world value plants and fungi related to Alaskan
species in traditional foods and medicines (Iriti et al., 2010; Kim
and Song, 2014).
The nematode Caenorhabditis elegans has homologous
neuronal features to humans that are vital for nervous system
function, which makes these animals a powerful model for
studying neuronal aging in vivo. Neither healthy brain aging
in humans nor neuron aging in C. elegans are characterized
by cell death (Herndon et al., 2002; Yankner et al., 2008).
Instead, age-related cognitive and functional decline in the
human brain is associated with neuroanatomical changes, such
as decreased white matter (i.e., myelinated neuron axons, glial
cells), altered dendritic branching, and decreased synaptic density
(Yankner et al., 2008), as well as decreased coordination and
altered localization of neuron/neural network activation (Bishop
et al., 2010). Recently, certain classes of C. elegans neurons,
including mechanosensory or touch receptor, neurons have been
shown to change morphologically with age (Pan et al., 2011;
Tank et al., 2011; Toth et al., 2012). Mechanosensory neurons
are central to an organism’s ability to sense and respond to
its environment. These neurons, including the anterior lateral
(ALM) and posterior lateral mechanosensory (PLM) neurons,
develop novel outgrowths from the soma and processes, and
deteriorated synapses with age, which can be observed with
fluorescently-tagged (GFP) genes and electron microscopy (Pan
et al., 2011; Tank et al., 2011; Toth et al., 2012). Assessing the
function and phenotypes of mechanosensory neurons within an
individual, provides a powerful model for exploring mechanisms
of neuronal aging and neurological effects of medicinal Alaskan
berries and fungus.
Modifying diet, specifically consuming fruits, vegetables, nuts,
and specific spices (e.g., turmeric, which contains curcumin), is
proposed to be a practical method to lower age-related cognitive
decline (Joseph et al., 2009). Alaskan plant and fungus species
have adapted to extreme environments, in part by producing a
wide variety of secondary metabolites, bioactive molecules not
required for plant growth and development (Wink, 2003; Elks
et al., 2013). Various plant and fungal extracts composed of
secondary metabolites interact with specific molecular targets
to improve health and to slow the progression of aging and
age-related disease damage (Liu et al., 2005; Wiegant et al.,
2008; Youl et al., 2010). For example, a large body of research
describes the anti-inflammatory and antioxidant activity of
polyphenolic compounds, such as anthocyanins (Zafra-Stone
et al., 2007). Berries in particular have been heavily studied
for their impact on brain signaling and neurodegeneration
(Spencer, 2008; Miller and Shukitt-Hale, 2012; Shukitt-Hale,
2012).
Alaskan berry species consistently contain higher levels
and activity of antioxidant and anti-inflammatory compounds
(e.g., phenolic, flavonoid, and anthocyanin compounds) than
other commercially grown, temperate species (Kalt et al., 2001;
Dinstel et al., 2013; Grace et al., 2014). The selected berries in
this study, bog blueberry (Vaccinium uliginosum, also known
as bog bilberry), lowbush cranberry (Vaccinium vitis-idaea,
also known as lingonberry), and crowberry (Empetrum nigrum,
also known as blackberry or mossberry), are found throughout
Alaska and the circumpolar north in bogs, woodlands, and
spruce stands. Non-Alaskan species of lowbush blueberries
(Vaccinium angustifolium) prevent and reverse object-
recognition memory loss in aging rats (Joseph et al., 1999)
and improve memory in both children (Whyte et al., 2015) and
older humans (Krikorian et al., 2010). Blueberry polyphenols
(V. angustifolium) also extend wild-type Caenorhabditis
elegans lifespan (Wilson et al., 2006). The American cranberry
(Vaccinium macrocarpon) extends C. elegans lifespan in a
dose-dependent manner (Guha et al., 2012). Crowberry contains
higher total anthocyanins than other well-studied berries,
such as blueberries, raspberries, and cranberries (Ogawa et al.,
2008), but little is known about its biological actions. Thus,
we set out to investigate the benefits of consuming Alaskan
berries.
Chaga (Inonotus obliquus, also known as cinder conk) is a
parasitic fungus found on birch trees; it has a long history of a
wide variety of medicinal uses in Asia and Eastern Europe, as
well as in Alaska. Chaga extracts exhibit high antioxidant activity
(Cui et al., 2005) and protect rat neuronal cells against oxidative
stress (Giridharan et al., 2011). Korean traditional knowledge
heralds chaga for its anti-cancer effects (Kim and Song, 2014) and
ergosterol peroxide extracted from chaga was recently shown to
inhibit cell growth by promoting apoptosis in a colorectal cancer
cell model (Kang et al., 2015). Taken together, consumption of
plants and fungi, especially those biochemically adapted to life
in the Arctic, is a promising approach to combating age-related
declines in function and development of disease.
The current study aims to describe the influence of Alaskan
medicinal berry and fungal treatments on the aging process. We
tested the hypothesis that treatments with blueberry, lowbush
cranberry, crowberry, and chaga increase wild-type C. elegans
lifespan and alter touch receptor neuron aging, potentially
through different cellular mechanisms. Specifically, we tested the
impact of specific treatments on lifespan and healthspan (i.e.,
motility, touch response, endogenous ROS). By examining the
six C. elegans touch receptor neurons throughout adulthood
using fluorescence microscopy, we also described the effects of
the treatments on age-related morphological changes. Studying
the impact of these culturally relevant foods on aging not only
provides further support for their ethnomedicinal use, but also
gives unique insights into the mechanisms of whole organism and
neuronal aging.
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MATERIALS AND METHODS
C. elegans Strains and Maintenance
The following strains were used in this study: N2 (Bristol),
ZB154 (zdIs5 [Pmec-4GFP; lin-15(+)]), and TJ375 (gpIs1[hsp-
16.2::GFP]). We used standard methods to maintain and
manipulate C. elegans populations (Brenner, 1974). Stock
populations were cultured at room temperature (about 22◦C) on
Nematode Growth Media agar plates (1 L NGM: 2.5 g peptone,
17 g agar, 3 g NaCl, 975 mL double distilled water, 1 mL 5 mg/mL
cholesterol, 1 mL 1 M CaCl2, 1 mL 1 M MgSO4, 25 mL 1 M
KHPO4, and 0.5 mL 100 mg/mL streptomycin) seeded with live
bacteria (E. coli strain OP50-1 cultured in Luria Broth) that were
allowed to form a lawn for 48 h at room temperature and then
stored at 4◦C until use.
Berry and Fungus Extract Preparation
We collected wild specimens of the selected species of natural
berries and fungus from Fairbanks, Alaska in late summer and
early fall 2012. A local Alaskan mycologist verified the identity
of chaga (Inonotus obliquus). All samples were stored whole and
fresh frozen at −80◦C until extraction. We prepared crude berry
extracts by blending and homogenizing ∼200 g frozen berries
with 500 mL chilled 80% aqueous acetone (∼4◦C) for 10 min
and removing the acetone with a rotary evaporator (∼120 min).
Specifically, 203.7 g of blueberries, 204.1 g of crowberries, and
200.6 g of lowbush cranberries were extracted to final volumes
of 334, 300, and 260 mL, respectively. We prepared crude chaga
extract by steeping 19.25 g of ground inner, deep orange core, of
the fungus in 50 mL of ∼80◦C water and filtering out leftover
particulates, to mimic common consumption of the fungus as
a tea-like infusion. We determined the stock concentrations of
extracts using a ratio of the starting mass of berry or fungus
to the final volume of extract. Extracts were then aliquoted
and stored at −80◦C. Freeze thaw cycles were limited to one
(thawed from −80◦C then aliquoted and frozen at −20◦C until
use) to ensure maximal preservation of bioactive components
(Lohachoompol et al., 2004). Because seasonal weather patterns
and location (e.g., bog versus mountain) have been shown to
influence the chemical makeup of various botanicals (Howell
et al., 2001), all experiments were conducted using extracts
prepared from the same extraction batch to eliminate the
potential for differences in the chemical properties of the
extracts.
Biochemical Quantification of Extracts
We quantified total phenolic content of each of the Alaskan
berry and fungus extracts using a Folin–Ciocalteu assay with
a gallic acid standard curve adapted for 96-well plate analysis
(Herald et al., 2012). We also measured flavonoid content with
a NaNO2/Al/NaOH assay with a catechin standard curve (Herald
et al., 2012). The gallic acid and catechin standard curves used
for comparison had R2 values of 0.98 and 0.96, respectively.
We quantified anthocyanin content by pH-differential assay
with cyanidin-3-glucoside equivalent (Song et al., 2013). Each
measurement included at least three technical replicates.
Berry and Fungus Treatment
Administration
To administer Alaskan berry and fungus treatments, we created
treatment agar plates by mixing the appropriate concentration of
extract into NGM after the agar cooled but prior to it solidifying.
Control plates consisted of NGM plates with no extract. We
seeded all plates with live OP50-1 E. coli cultured from single
bacterial colonies in Miller Luria-Bertani (LB) Broth containing
50 µg/mL streptomycin. During all experiments, we ensured that
the experimenter was blinded to the treatment groups. In the
following described experiments (unless otherwise mentioned),
synchronous populations of the appropriate C. elegans strains
were created on standard, untreated NGM agar plates using
the egg lay method (i.e., allow 30 gravid adults to lay eggs
for 4 h, then removing the adults), fed standard live OP50-
1 E. coli, and cultured at 25◦C. We transferred experimental
populations by hand to treatment plates at the late L4 larval
stage, just before adulthood (48 h at 25◦C after egg lay),
allowing the animals to ingest the extract after normal larval
development.
Lifespan Analysis
Following the production of age-synchronous L4 populations via
egg lay, we transferred two replicates of 25 animals onto plates
for each berry and fungus treatment. We continued to transfer
animals at least every other day of adulthood to fresh, seeded agar
plates with the appropriate treatment. After all treatment groups
stopped producing eggs, we continued to determine survival at
least every other day by visual observation or gentle prodding
with a platinum wire. At any point during the experiment,
animals with protruding intestines, internal live young, or that
crawled off the plates were censored. Survival experiments
always included an untreated control in parallel with berry
and fungus treatments and were repeated at least three times.
For lifespan experiments using UV irradiated bacteria, berry
and fungus treatment administration and agar plate preparation
were performed in the same manner as all other experiments
with the additional step of exposing prepared OP50-1 lawns
to 9999 J/m2 254 nm UV light using a UV Stratalinker 1800
and testing for survival before use. We used Kaplan–Meier log-
rank survival statistics to analyze differences in mean survival
between treatment groups. For this and all other statistical
analyses described, we used the statistical software SPSS (version
20) and considered a p-value of less than 0.05 statistically
significant.
Motility Measurement
We divided aging individuals’ motility into three classes: A, B,
and C, following the methods of Herndon et al. (2002). Class
A individuals moved spontaneously in a normal, sinusoidal
pattern. Class B individuals moved in markedly non-sinusoidal
movements and may have required prodding to encourage
movement. Class C individuals moved their head and/or tail
in response to prodding, but were unable to move across the
agar. Treatment effects were compared to their age-matched no
treatment control using an ordinal logistic statistics model.
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Reactive Oxygen Species Quantification
To begin treatment on large age-matched populations, we washed
late L4 populations (48 h after bleaching at 25◦C) onto treatment
plates with M9 (autoclaved 3 g KH2PO4, 5 g NaCl, 6 g
Na2HPO4∗7H2O and sterile 1 mL 1 M MgSO4 in 1 L H2O). On
test day (48 h after treatment, day 3 of adulthood), we isolated
300–500 adult worms from each treatment group by washing
populations through a 50 µm filter with M9. We then quantified
reactive oxygen species (ROS) using H2DCF-DA (Halliwell and
Whiteman, 2004). To do this, we: transferred the live adults into
labeled 2 mL tubes using 1.5 mL M9 buffer; allowed them to
settle by gravity; removed the supernatant such that 500 µL of
M9 was left in the tube; and pipetted three aliquots of 50 µL
of the well-mixed M9-worm solution to the appropriate 96-
well plate well. Immediately before loading the plate into the
Biotek SynergyTM HT Multi-Mode Microplate Reader, we added
50 µL of 100 mM 2′,7′-Dichlorofluorescin diacetate (DCF-DA,
Sigma) in M9 to each well. We recorded basal fluorescence
(excitation 485 nm, emission 520 nm), stored the plate in the
dark at room temperature on a shaker for 1 h, and recorded
final fluorescence. We normalized fluorescence results to basal
worm and basal DCF-DA fluorescence (50 µM DCF-DA in M9
buffer). Results were also normalized to total protein in each tube
(using the leftover 200 µL of M9-worm solution in the 2 mL
tube, described above) using the Pierce BCA Protein Assay on
the supernatant following worm lysis (20 µL 1 M NaOH to each
tube incubated for 25 min at 70◦C). This ROS quantification
protocol was performed three times and was adapted from
other published protocols (Braeckman et al., 2002; Schulz et al.,
2006).
Fecundity Measurement
To determine whether fecundity, specifically the number of viable
progeny produced, was affected by treatments, we performed
progeny count assays. We individually plated and transferred
age-matched adults each day to fresh plates until the end of their
reproductive phase or death. We allowed embryos left behind by
the adults each day to develop for 48 h at 25◦C and then manually
counted the number of progeny produced by each individual on
each day. We compared the total number of progeny produced
per treatment and control using one-way ANOVA and Tukey post
hoc comparisons. We tested for treatment effects on each day of
adulthood using a Poisson log linear statistical model.
Mechanosensory Neuron Aging Assay
We performed neuron aging assays (i.e., soft touch response and
mechanosensory neuron imaging) using the C. elegans strain
zdIs5, which expresses green fluorescent protein (GFP) in each
of the six touch receptor neurons (Figure 3A). On days 5, 7, 9,
and 11 of adulthood, we randomly selected individuals from a
synchronous population, tested for touch sensitivity, and imaged
the number and type of specific neuronal aberrations seen in
the six fluorescently labeled neurons. We measured soft touch
sensitivity and observed mechanosensory neuron aberrations as
established by Toth et al. (2012), by counting the number of
positive responses an individual had to five alternating touches
at each the anterior and posterior ends (10 total touches). To
image the fluorescently labeled neurons, we then mounted that
individual on a labeled coverslip with 36% Pluronic solution
and quantified neuron morphology with an Olympus FSX100
inverted fluorescent microscope at 20× magnification (for an
overall magnification of 200×). Neuron morphologies observed
included those previously described (Pan et al., 2011; Tank
et al., 2011; Toth et al., 2012; Scerbak et al., 2014), such as
various lengths of outgrowths from the soma, branches from
the process, abnormally shaped soma, punctae on the process,
and soma in the wrong location. This assay of mechanosensory
neuron form and function was repeated at least three times
for each selected Alaskan berry and fungus lifespan-extending
treatment and each replicate contained its own distinct untreated
control group. We performed Poisson log linear (for count data,
i.e., number of outgrowths) or logistic regression (for bimodal
data, i.e., presence of abnormal cell soma) statistical models
to test for treatment and age effects on touch sensitivity and
neuron morphologies. Pairwise comparisons with p ≤ 0.05 were
considered significant.
hsp16-2::GFP Gene Expression Assay
hsp-16.2::GFP reporter gene expression assays were performed
on age-matched day 3 adults cultured on appropriate berry and
fungus treatment plates at 20◦C using 8× magnification on an
Olympus FSX100 inverted fluorescent microscope (for an overall
magnification of 80×) and constant exposure. Positive control
animals were heat shocked at 37◦C for 90 min, 20 h before
imaging (Rea et al., 2005). To detect treatment effects, we used
a one-way ANOVA with Tukey post hoc statistical tests.
RESULTS
Standardization of Alaskan Plant and
Fungus Extracts
Polyphenolic compounds, including flavonoids and
anthocyanins, exhibit potent antioxidant and anti-inflammatory
properties (Joseph et al., 2014). We quantified three measures
of phenolic content to compare the extracts used in this study
with others shown to have bioactive properties and other
Alaskan berry extracts shown to contain high phenolic content.
Total phenolic content (Folin–Ciocalteu assay with gallic acid
equivalent), flavonoid content (NaNO2/Al/NaOH assay with
catechin equivalent), and anthocyanin content (pH-differential
with cyanidin-3-glucoside) of each extract were measured
using established methods (Table 1) (Herald et al., 2012; Song
et al., 2013). The relative abundance of total phenolics and
anthocyanins of blueberry compared to lowbush cranberry
levels was the same as previously reported for Alaskan blueberry
and lowbush cranberry (Grace et al., 2014); total phenolic
content was 443% higher in lowbush cranberry than blueberry
while anthocyanin content was 137% higher in blueberry than
cranberry (Table 1). The crowberry extract contained the highest
levels of total phenolics and anthocyanins of all the extracts. In
contrast, the chaga extract contained the lowest levels of total
phenolics, flavonoids, and anthocyanins of all the extracts.
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TABLE 1 | Biochemical quantification of crude extracts.
Total phenolic content (mg GAE g−1 FW) Flavonoid content (mg CAE 100 g−1 FW) Anthocyanin content (mg C3G L−1 FW)
Blueberry 190.4 ± 4.0 202.3 ± 1.4 217.4 ± 5.3
Lowbush cranberry 219.6 ± 6.4 896.2 ± 8.6 158.4 ± 5.3
Chaga 74.9 ± 3.3 125.9 ± 3.1 5.5 ± 2.6
Crowberry 365.3 ± 9.2 453.2 ± 30.1 713.9 ± 45.2
Total phenolic content (quantified by Folin–Ciocalteu assay with gallic acid equivalent), flavonoid content (quantified by NaNO2/Al/NaOH assay with catechin equivalent),
and anthocyanin content (quantified by pH-differential with cyanidin-3-glucoside) ± standard error of the mean for each berry and fungus extract is reported.
FIGURE 1 | Alaskan berry and fungus treatments extend wild-type C. elegans lifespan. Representative survival curves for each berry and fungus treatment
(A–C) and induced percent change in lifespan relative to control for all replicates (D–F) are shown (N = 50 per treatment group). Asterisks denote significant lifespan
extension (p < 0.05; Kaplan–Meier log-rank test) from control in 75% or more (∗∗∗) and 60% or more (∗∗) of 4–6 independent trials. Bars represent mean ± standard
error of the mean between all replicates of a treatment dose.
Alaskan Berry and Fungus Treatments
Extend C. elegans Lifespan
Under our laboratory culture conditions (i.e., 25◦C, solid
media, live OP50-1 E. coli food source), C. elegans untreated
control mean lifespan was 10.2 ± 0.4 days. Three of the
four tested Alaskan berry and fungus treatments resulted in
wild-type C. elegans lifespan extension: blueberry, lowbush
cranberry, and chaga treatments extended lifespan at varying
doses and to different extents when compared to untreated
control populations (Figure 1 and Table 2). Blueberry treatment
elicited the highest increase in lifespan of all tested Alaskan
berries and fungus; an average of 30% and up to 47% (200 µg/mL
treatment) when compared to untreated control. Blueberry was
also the only treatment for which an entire range of doses tested
(60–400 µg/mL) resulted in lifespan extension (Figure 1D). In
a representative trial, mean lifespan significantly increased over
the no treatment control to 12.4± 0.6, 11.2± 0.6, 12.4± 0.7, and
11.2± 0.6 days upon treatment with 60, 100, 200, and 400 µg/mL
Alaskan blueberry extract, respectively (p < 0.05, Kaplan–Meier
log-rank test). Treatment with 800 µg/mL blueberry did not
consistently, statistically increase lifespan.
Both lowbush cranberry (Figure 1E) and chaga (Figure 1F)
treatments resulted in a bimodal response in lifespan extension.
Two of the five selected lowbush cranberry treatment doses
significantly increased lifespan: 50 and 400 µg/mL. Both
50 and 400 µg/mL lowbush cranberry treatments reliably,
statistically increased lifespan up to 22% when compared to
control. Treatment with 50, 200, and 800 µg/mL chaga extract
significantly increased mean lifespan to 13.1 ± 0.6, 12.9 ± 0.5,
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TABLE 2 | Alaskan berry and fungus treatments extend wild-type C. elegans lifespan.
Treatment N Mean lifespan ± SEM Percent of control p-value Highest increase observed Lowest increase observed
Blueberry dose (µg/mL)
0 60 9.48 ± 0.31
60 66 12.4 ± 0.56 156% <0.0001 128% 107%
100 60 11.2 ± 0.59 147% <0.0001 144% 111%
200 51 12.4 ± 0.73 146% 0.001 147% 120%
400 58 11.2 ± 0.58 139% <0.0001 139% 120%
800 60 9.31 ± 0.28 109% 0.341 117% 109% (n.s.)
Lowbush cranberry dose (µg/mL)
0 50 11.3 ± 0.58
50 50 13.9 ± 0.91 122% 0.012 122% 116%
100 51 11.1 ± 0.50 102% 0.868 116% 104% (n.s.)
200 50 12.5 ± 0.49 110% 0.123 119% 106%
400 50 13.9 ± 0.89 122% 0.016 122% 108%
800 50 12.5 ± 0.28 107% 0.229 119% 108% (n.s)
Chaga dose (µg/mL)
0 50 10.7 ± 0.50
50 49 13.1 ± 0.60 122% 0.002 122% 113%
200 50 12.9 ± 0.55 121% 0.005 124% 117%
800 47 12.9 ± 0.65 121% 0.003 121% 116%
Percent change in lifespan relative to control, significance from the representative survival curves shown in Figures 1A–C. The highest and lowest percent increase in
lifespan relative to control in all replicates is also reported. Experiments were repeated in multiple independent trials (≥3), all with the same directional effect and similar
magnitude of effect. Statistical significance (p-value) calculated with Kaplan–Meier log-rank test.
and 12.9 ± 0.6 days, respectively, compared to a control of
10.7 ± 0.5 days in a representative trial (p < 0.05, Kaplan–
Meier log-rank test). In addition to the effective chaga treatments
doses shown in Figure 1C, we observed no significant change in
mean or median lifespan at several additional doses (10, 20, and
100 µg/mL; Figure 1F). Crowberry treatment was also tested for
lifespan extension at similar treatment doses as blueberry, but no
significant effect was observed (Supplementary Figure S1).
Next, we investigated whether the lifespan-extending effects
of blueberry, lowbush cranberry, and chaga were primarily due
to secondary responses in C. elegans to an altered food source,
OP50-1 E. coli exposed to the same treatment. OP50-1 E. coli
growth in liquid culture was unaffected by the presence of
Alaskan nutraceuticals at C. elegans lifespan-extending doses
(data not shown). We also measured C. elegans lifespan on
Alaskan berry and fungus treatments with UV irradiated OP50-
1 E. coli. Both blueberry and lowbush cranberry treatments
resulted in extended wild-type lifespan when compared to
untreated control, even with UV-killed bacteria (p < 0.05;
Kaplan–Meier log-rank test; Supplementary Figure S2). However,
chaga treatment did not extend lifespan when C. elegans were
fed UV-killed bacteria (0.09 < p < 0.4; Kaplan–Meier log-rank
test).
Alaskan Berry and Fungus Treatments
Improve Healthspan
Interventions that increase lifespan do not necessarily increase
health with age nor decrease the proportion of time spent living
in a frail state (Bansal et al., 2015). To address this possibility
with Alaskan berry and fungus treatments that extended lifespan
(Figure 1), we studied several measures of healthspan. In
C. elegans, the ability to move spontaneously and actively (i.e.,
motility) declines stochastically (Herndon et al., 2002). At mid-
life (day 5 of adulthood), both control and lifespan-extending
Alaskan berry and fungus treatments tested had nearly 100%
normal motility, as expected (Figures 2A–C). However, all of
the lifespan-extending Alaskan berry and fungus treatments
maintained healthy motility well into late adulthood (day 11)
by significantly increasing the ratio of normally, spontaneously
moving adults (Class A) to abnormally, non-spontaneously
moving (Class B) and frail, immobile (Class C) adults (p < 0.01
ordinal logistic model; Figures 2D–F). There were no dose-
dependent effects on motility within blueberry and lowbush
cranberry treatments (p > 0.2, ordinal logistic model). Then,
800 µg/mL chaga treatment significantly decreased the incidence
of Class C adults at Day 11 of adulthood when compared to
control, 50, and 200 µg/mL chaga (p < 0.001, ordinal logistic
model).
The ability to sense and respond to touch (i.e., touch
response) also decreases with age in C. elegans. We observed a
significant age-related decrease in both anterior and posterior
touch response (i.e., the number of positive responses to five
touches at the anterior or posterior end of the animal) in all
control groups, as expected (Figure 3, black bars). Overall,
lifespan-extending Alaskan berry and fungus treatments slowed
this decline in mechanosensation by late adulthood (day 9 or
day 11; Figure 3). Both blueberry treatments robustly improved
anterior (1.75 ± 0.15 control vs. 2.5 ± 0.15 60 µg/mL and
2.4 ± 0.16 200 µg/mL; p < 0.02) and posterior touch response
(2.7 ± 0.14 control vs. 3.4 ± 0.13 60 µg/mL and 3.2 ± 0.14
200 µg/mL; p < 0.02) at day 11 when compared to age-matched
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FIGURE 2 | Lifespan-extending Alaskan berry and fungus treatments improve wild-type C. elegans motility late in life. Percent per motility class of
middle age (day 5 adults; A–C) and old age (day 11 adults; D–F) for lifespan-extending Alaskan blueberry (A,D), lowbush cranberry (B,E), and chaga (C,F) are
shown. Class A animals (green bars) moved normally and spontaneously, class B animals (yellow bars) moved abnormally and may have required prodding, and
class C animals (red bars) were unable to translocate. N = 28–58 animals from at least three separate biological replicates per treatment group.
control. Low dose lowbush cranberry treatment (50 µg/mL)
improved both anterior and posterior touch response over
control at day 11 of adulthood (anterior: 1.7± 0.14 vs. 2.2± 0.18;
posterior: 3.1 ± 0.11 vs. 3.3 ± 0.11; p < 0.05). The higher
lowbush cranberry treatment (400 µg/mL) improved posterior
touch response at day 9 of adulthood (3.75 ± 0.11 vs. 3.9 ± 0.11;
p < 0.02), then dropped to control levels at day 11 (3.1 ± 0.11
vs. 3.26 ± 0.11; Figure 3E). Two of the three lifespan-extending
chaga treatments improved touch response: both 50 (2.63± 0.18)
and 200 µg/mL (2.82 ± 0.21) chaga treatments significantly
improved anterior (but not posterior) touch response compared
to control (2.0± 0.16) at day 11 (p < 0.05).
Reactive oxygen species are considered a biomarker of overall
health and are associated with aging (Kregel and Zhang, 2007;
Campos et al., 2014; Stuart et al., 2014). To test the hypothesis
that lifespan-extending berry and fungus treatments decrease
damaging ROS early in life, we measured ROS within whole, live
young adult (day 2) C. elegans populations using H2DCF-DA.
Blueberry, lowbush cranberry, and chaga treatments differentially
influenced endogenous management of ROS (Figure 4A).
Treatment with blueberry trended toward increasing ROS levels
(113.7% of control; p = 0.085; One-way ANOVA) while
chaga treatment strikingly decreased ROS (53.5% of control;
p = 0.06; One-way ANOVA). Lowbush cranberry treatment
had no effect on ROS early in adulthood when compared
to control (p = 1.0; One-way ANOVA), although lowbush
cranberry-mediated ROS levels were not significantly different
from chaga treatments. Increased expression of the heat shock
protein HSP-16.2 is a marker for ROS stress within C. elegans. To
further describe ROS stress in young adults treated with lifespan-
extending Alaskan berry and fungus treatments, we measured
the hsp-16.2::GFP gene reporter fluorescence in the pharynx
(Figures 4B–G). Blueberry treatment significantly increased hsp-
16.2::GFP expression (146% of control; p < 0.05; One-way
ANOVA). Both chaga and lowbush cranberry treatments did
not significantly alter hsp-16.2::GFP gene expression (p > 0.2;
One-way ANOVA).
Interventions that increase aging are often associated with a
decrease in fecundity (Jafari and Rose, 2006). We found that
lifespan-extending Alaskan berry and fungus treatments did
not influence total progeny produced per individual (p > 0.7;
One-way ANOVA; N = 24 per treatment; Table 3). When we
considered the number of progeny produced per individual
on specific days of adulthood, the blueberry treatments had
numerically small (<15 progeny) but significant effects (p< 0.05;
One-way ANOVA with Tukey post hoc analysis). However, no
treatments extend the number of days individuals produced
viable progeny (Supplementary Figure S3).
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FIGURE 3 | Lifespan-extending Alaskan berry and fungus treatments improve wild-type C. elegans gentle touch response late in life. Anterior (A–C)
and posterior (D–F) mean touch score for each treatment group is shown. Asterisks denote significance from age-matched control (p < 0.05; Poisson log linear
model). Bars represent mean ± standard error of the mean. N = 28–58 animals from at least three separate biological replicates per treatment group.
Alaskan Berry and Fungus Treatments
Differentially Alter Mechanosensory
Neuron Aging
C. elegans mechanosensory neurons sense soft touch and exhibit
changes in morphology with age and with modifications in
cellular signaling (Pan et al., 2011; Tank et al., 2011; Toth
et al., 2012). To visualize these morphological changes with age,
we used a C. elegans strain with GFP-labeled touch receptor
neurons (zdIs5 [mec-4p::GFP]). There are six C. elegans touch
receptor neurons: two anterior lateral (ALML, ALMR), one
anterior ventral (AVM), two posterior lateral (PLML, PLMR),
and one posterior ventral (PVM), which are illustrated in
Figure 5A. This study focused on the two pairs of lateral
neurons because they are the most sensitive to change with
age. The four lateral neurons (ALML, ALMR, PLML, and
PLMR) are typified by a circular cell body (soma) and a
single, straight process (representing the axon and dendrites)
extending toward the anterior end of the animal. Posterior
neurons have an additional outgrowth from the soma toward
the posterior of the animal. We considered any morphological
deviations from this norm to be “neuronal aberrations,”
but did not assume that these aberrations were functionally
deleterious.
In all treatments, we observed similar morphological
changes with age in the untreated control groups, as expected
(Figures 5–7; black bars). Notably, as they aged, all control
populations exhibited significantly increased numbers of total
aberrations per anterior cell (day 11 is 179% of day 5 levels;
p < 0.05; Poisson log linear model; Figure 5B; black bars) and
total aberrations per posterior cell (day 11 is 3154% of day 5
levels; p < 0.05; Poisson log linear model; Figure 6A; black
bars). In anterior cells, the total number of extended outgrowths
increased with age (day 11 is 469% of day 5 levels; p < 0.05;
Poisson log linear model; Figures 5D and 7B; black bars). In
posterior cells, an increase in process branching was the primary
driver for the increased total aberrations per cell (increased
from no occurrences at day 5 to 23.2% occurrence at day 11;
p < 0.05; Poisson log linear model; Figure 6B; black bars). These
findings generally align with previously described age-related
morphological changes observed in touch receptor neurons (Pan
et al., 2011; Tank et al., 2011; Toth et al., 2012).
Blueberry treatments that significantly extended lifespan (60
and 200 µg/mL) decreased the total number of aberrations
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FIGURE 4 | Lifespan-extending Alaskan berry and fungus treatments change endogenous ROS levels in young wild-type C. elegans. (A) The change in
endogenous ROS measured by DCF-DA after treating young adults for 48 h with selected lifespan-extending Alaskan berry and fungus treatments is shown. The
percent change on a logarithmic scale of hsp16.2::GFP expression in the pharynx region of young adults treated for 48 h with selected berry and fungus treatments
relative to untreated control (B) and representative images (C–G) are also shown. Note the extreme increase in hsp16.2::GFP expression in response to heat shock.
Bars represent mean ± standard error of the mean of each replicate, each with two or three technical replicates for the DCF-DA assay. Hashtag (p = 0.085) and
asterisks (p < 0.06; one-way ANOVA with Tukey post hoc) denote significance from 0 µg/mL control.
TABLE 3 | Alaskan berry and fungus treatments do not alter total progeny
produced by wild-type C. elegans.
Treatment Total progeny
produced per adult
(mean ± SEM)
Blueberry dose (µg/ml) 0 190.7 ± 27.5
60 198.2 ± 13.9
200 195.2 ± 38.0
Lowbush cranberry dose (µg/ml) 0 183.4 ± 19.3
50 201.7 ± 10.2
400 198.3 ± 7.2
Chaga dose (µg/ml) 0 173.4 ± 7.47
50 174.9 ± 14.7
200 188.1 ± 4.6
Experiments were repeated in three independent trials each with N = 8 parents per
treatment group, all with no significant effect observed.
observed per animal relative to control by day 11 of adulthood
(79.2 and 71.8% of control; p < 0.05; Poisson log linear model).
At the cellular level, only anterior lateral neuron morphology
was altered with blueberry treatment (86.2 and 76.2% of control;
p < 0.05; Poisson log linear model; Figure 5B). The primary
aberration driving this difference in anterior neuron morphology
with blueberry treatment was soma outgrowths (90.9 and 77.6%
of control levels; p < 0.05; Poisson log linear model; Figure 5C),
specifically extended soma outgrowths (<2× soma diameter;
Figure 5D). The percent of anterior cell somas with an abnormal
shape or location significantly decreased with 200 µg/mL
blueberry treatment day 11 of adulthood (67.4 and 56.5% of
control; p < 0.05 Poisson log linear model; Figure 5G) and
was the only other specific aberration significantly altered with
blueberry treatment. Conversely, on day 5 of adulthood, low
dose blueberry (60 µg/mL) treatment significantly increased
extended outgrowths and significantly decreased percent cells
with abnormal cell bodies (p < 0.05; Poisson log linear model),
suggesting that a relationship between these two aberrations
exists early in life. Posterior touch receptor neuron aging was
unaffected by blueberry treatment (p > 0.8; Poisson log linear
model).
In contrast to blueberry treatment, lowbush cranberry
treatment increased only posterior cell aberrations (Figure 6A).
Treatment with low dose lowbush cranberry (50 µg/mL)
significantly increased total posterior cell aberrations both at
mid-life (day 5; 719% of control) and old age (day 11; 177%
of control; p < 0.01; Poisson log linear model). This increase
in total aberrations was due solely to increased posterior cell
process branching compared to control by day 11 of adulthood
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FIGURE 5 | Alaskan blueberry treatments alter the accumulation of aberrations in aging anterior touch receptor neurons. Animals from control and
lifespan-extending blueberry treatments (60 and 200 µg/mL) were imaged for touch receptor neuron aberrations at days 5, 7, 9, and 11 of adulthood. A schematic
of the locations of the six GFP-labeled touch receptor neurons (A) is shown. Neuron aging markers in order of broad to more specific effects are shown: Mean
number of total aberrations (B), soma outgrowths (of all lengths) (C), extended outgrowths (≥2× longer than soma diameter) per anterior (ALM) neuron (D) are
shown along with representative images of ALM somas free of aberrations (E) and with extended outgrowth (F). Percent of all anterior cells imaged with abnormal
somas (G) is shown along with example ALM neurons with abnormal somas (H–K). Bars represent mean ± standard error of the mean. Asterisks (p < 0.05) and
hashtags (p < 0.08) denote significance from age-matched control. Nworms = 28–62 and Nanterior cells = 48–101 per bar. White arrowheads denote location of
specific aberration. All images were collected at 20× magnification and were cropped to the same scale (no other image processing was performed). White scale
bars are 10 µm.
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FIGURE 6 | Alaskan lowbush cranberry treatments increase occurrence of process branching in aging posterior touch receptor neurons. Animals from
control and lifespan-extending lowbush cranberry treatments (50 and 400 µg/mL) were imaged for touch receptor neuron aberrations at days 5, 7, 9, and 11 of
adulthood. Mean number of total aberrations (A) and branches observed on the dentrite/axon per posterior lateral touch receptor (PLM) neuron (B) are shown.
Representative images of posterior neuron processes with no aberrations (C,D), with one process branch (E), and with multiple process branching events (F) are
also shown. Bars represent mean ± standard error of the mean. Asterisks (p < 0.05) and hashtags (p < 0.085) denote significance from age-matched control.
Nposterior cells = 48–73 per bar. In all images, the anterior end of the animal is to the right and posterior lateral touch receptor (PLM) neurons are shown. All images
were collected at 20× magnification and were cropped to the same scale (no other image processing was performed). White scale bars are 10 µm.
(Figure 6B). Anterior cell aberration development with age
was unaffected by 50 µg/mL lowbush cranberry treatment
(p > 0.8; Poisson log linear model). The higher lowbush
cranberry treatment (400 µg/mL), which also increased lifespan,
had no effect on age-related development of posterior cell
aberrations (p> 0.1; Poisson log linear model). Then, 400 µg/mL
lowbush cranberry treatment significantly decreased the number
of anterior cell aberrations by day 11 of adulthood (83.1%
of control; p < 0.05; Poisson log linear model), but we are
unable to relate this decrease to any specific type of neuronal
aberration.
Treatment with lifespan-extending chaga doses elicited effects
similar to both blueberry and lowbush cranberry treatments:
both anterior cell soma outgrowths and posterior cell process
outgrowth events were impacted (Figure 7). While chaga
treatment did not significantly alter the accumulation of total
anterior cell outgrowths with age (p > 0.8; Poisson log linear
model; Figure 7A), these treatments did affect the lengths of
the soma outgrowths observed. In all three chaga treatments,
the occurrence of extended outgrowths (≥2× soma diameter)
significantly decreased compared to control at day 11 of
adulthood (43.3–52.8% of control; p < 0.05; Poisson log linear
model; Figure 7B). Conversely, short soma outgrowths (<1×
soma diameter) increased by day 11 with chaga treatment (153–
210% of control; p < 0.05; Poisson log linear model; Figure 7C).
Posterior cell process outgrowths, which consist of both straight
branches pointing away from the process and branches that
loop back to the process (i.e., loops), were affected by all three
chaga treatments later in life (166–403% of control; p < 0.05;
Poisson log linear model; Figure 7D). Specifically, treatment
with low dose chaga (50 µg/mL) significantly reduced posterior
cell process outgrowths at day 9 of adulthood (8.3% of control;
p < 0.05; Poisson log linear model), but these aberrations rose
to control levels at day 11 (p > 0.2; Poisson log linear model).
Treatment with 200 µg/mL chaga quadruples the occurrence
of posterior cell process outgrowths at day 11 of adulthood
compared to control (403% of control; p < 0.05; Poisson log
linear model). High dose chaga treatment (800 µg/mL) caused
a significant decrease in posterior cell process outgrowths at day
9 of adulthood compared to control and a significant increase
by day 11 (241% of control; p < 0.05; Poisson log linear
model).
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FIGURE 7 | Alaskan chaga treatments impact aging anterior and posterior touch receptor neurons. Animals from control and lifespan-extending chaga
treatments (50, 2, and 800 µg/mL) were imaged for touch receptor neuron aberrations at days 5, 7, 9, and 11 of adulthood. The total number of anterior cell soma
outgrowths was unchanged with chaga treatment (A), but the mean number of extended outgrowths (≥2× longer than soma diameter) (B) and short soma
outgrowths (<1× soma diameter) per anterior cell (C) were impacted. Posterior cell process outgrowths (D) represents branching or loop phenotypes observed from
the axon and/dendrites of the two posterior lateral neurons (PLM). Representative images of short soma outgrowths (E), standard soma outgrowth (1× soma
diameter; F), different length soma outgrowths (G) and extreme aberrations (H) are also shown. Bars represent mean ± standard error of the mean. Asterisks
(p < 0.05) denote significance from age-matched control. Nworms = 28–50, Nanterior cells = 50–95, and Nposterior cells = 56–100 per bar. All images were
collected at 20× magnification and were cropped to the same scale (no other image processing was performed). White scale bars are 10 µm.
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DISCUSSION
Compared to the modern “Western” lifestyle, traditional North
American Native and subsistence lifestyles are associated with
lower incidence of age-related and chronic disorders, particularly
cardiovascular disease (Ebbesson et al., 2005; Mohatt et al.,
2007). Differences in the diet of these two lifestyles are proposed
factors for the improved health. To further explore the influence
of traditional food sources on the functional aging process,
we tested the effects of Alaskan berry and fungus extracts on
C. elegans lifespan, healthspan, and markers of touch receptor
neuron aging. Alaskan blueberry, lowbush cranberry, and chaga
treatment increased lifespan at varying doses (i.e., 50–800µg/mL;
Figure 1 and Table 2). Increased lifespan may be uncoupled from
improved health in old age (e.g., healthspan), thus measuring
length of life alone does not necessarily provide an accurate
portrayal of aging (Bansal et al., 2015). We find that measures
of healthspan are either improved (i.e., motility, touch response;
Figures 2 and 3) or not affected (i.e., total viable progeny
produced; Table 3) throughout the lifespan of animals treated
with Alaskan berries and fungus. Each of the Alaskan berry and
fungus treatments resulted in varied touch receptor neuron aging
trajectories, with both decreased incidence of anterior neuron
(ALM) soma outgrowths and increased incidence of posterior
neuron (PLM) process branching (Figure 8). Nonetheless, both
changes correlated with improved touch response (Figures 3
and 5–8). Importantly, this suggests that the development of
specific touch receptor neuron morphologies impact neuronal
and organismal function differently and reflects the importance
of examining multiple healthspan markers in aging studies.
These findings demonstrate that beneficial nutritional lifespan
interventions differentially impact touch receptor neuron aging
and, thus, support the body of research describing numerous
cellular strategies leading to increased lifespan and improved
health (reviewed in Lopez-Otin et al., 2013).
Alaskan blueberry treatment effects are distinct from the other
treatments; blueberry elicited the greatest increase in lifespan
(up to 47%) and improved both anterior and posterior touch
response late in life, while only impacting ALM morphology (i.e.,
decreased extended soma outgrowths and incidence of abnormal
cell bodies; Figure 5). There is also a time-dependent and dose-
dependent response to blueberry treatment that is unique from
the other Alaskan nutraceutical treatments. First, middle-aged
adults (day 5) treated with 60 µg/mL blueberry exhibit a touch
receptor neuron phenotype associated with decreased health later
in life (i.e., increased incidence of extended outgrowths from
anterior cell somas; Figure 5D) and no improvement in other
markers of healthspan (i.e., motility, Figure 2A; touch response,
Figures 3A,D). Second, the higher 200 µg/mL treatment elicited
a significant decrease in extended outgrowths by late life (day
11), while 60 µg/mL did not (Figure 5D). Also, in young
adults (day 2) treated with 200 µg/mL blueberry, we observed
increased levels of damaging ROS within live animals and
increased hsp-16.2::GFP expression, a marker of ROS stress
when compared to controls (Figure 4). Importantly, heat-shock
treatments, which induce hsp-16.2::GFP expression, are known
to result in improved stress response via hormetic mechanisms
(Link et al., 1999). Blueberry treatment (200 µg/mL) also slightly,
but significantly, decreased the number of progeny produced
on day 2 of adulthood (27 ± 13.1 fewer progeny than control;
Supplementary Figure S3) but did not impact total progeny
produced over reproductive lifespan; again suggesting that early
in life, blueberry treatment induces stress-response signaling.
These dose- and time-dependent results indicate an
involvement of two interesting biological phenomenon in
the blueberry treatment effects: hormesis and xenohormesis.
Hormesis describes the dose-dependent effect wherein low
doses of a treatment elicit a beneficial response while high
doses of the same treatment are elicit a negative response or
are toxic. Xenohormesis is the adaptive, defensive response
FIGURE 8 | Schematic summary of results. Non-treated wild-type aging C. elegans touch receptor neurons exhibit increased extended outgrowths from the
anterior neuron (ALM) soma and increased abnormal ALM soma by late life (day 11 of adulthood). Alaskan berry and fungus treatments impact this neuron aging
trajectory by blocking accumulation of ALM aberrations (i.e., blueberry), increasing the incidence of posterior neuron (PLM) aberrations (i.e., lowbush cranberry), or
both (i.e., chaga) when compared to age-matched controls. Nevertheless, all three treatments significantly increase lifespan and improve markers of healthspan (i.e.,
motility and touch response late in life).
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of animals to consuming secondary metabolites produced by
environmentally stressed plants (e.g., polyphenols; Howitz
and Sinclair, 2008). Xenohormesis may also be described as
one organism (i.e., the consumer) benefiting from the stress
response, or hormesis, of another organism (i.e., the plant). This
intra-species signaling is proposed to activate stress-response
signaling in animals via interactions with signaling molecules
(as opposed to general antioxidant effects), which improves
the health and survival of the consumer (Howitz and Sinclair,
2008). Xenohormesis may be involved in the blueberry treatment
effects because of the increased C. elegans lifespan following the
consumption of Alaskan blueberry extract, which is known to
have elevated polyphenolic content relative to other blueberry
species (Grace et al., 2014), indicative of UV-stress. Additionally,
the observation of a detrimental neuronal phenotype coupled
with increased markers of ROS stress and decreased progeny
early in life followed by improved lifespan, healthspan, and touch
receptor neuron health late in life suggests that hormesis within
the worm is likely also occurring.
Others have proposed that polyphenols, including extracts
from blueberry, exert their effects on stress-response and
longevity through mechanisms other than antioxidant activity,
such as hormesis and xenohormesis. For example, Elks et al.
(2011) observed that feeding a hypertensive rat model a
blueberry-enriched diet improved renoprotection and oxidative
stress markers in the long term (6 or 12 weeks) but increased
oxidative stress in the short term (2 days). These authors also
proposed xenohormesis as a mechanism of blueberry treatment
effects. Additionally, Wilson et al. (2006) found that treatment
with non-Alaskan, wild lowbush blueberry polyphenols not only
increased lifespan but also improved response to heat stress
and thermotolerance, processes that are markers of an adaptive
response to a stressor (Gems and Partridge, 2008). Blueberry
extracts have also been shown to modulate biological responses
(e.g., inhibition of inflammation) at treatment doses low enough
to preclude the action of antioxidants as ROS scavengers as
the sole explanation of their effects in neuronal cell culture
(Gustafson et al., 2012). Interactions of specific polyphenolic
compounds with diverse cellular signaling pathways outside of
antioxidant signaling involved in aging have also been described
(e.g., quercitin from apples and insulin signaling; Youl et al.,
2010). These results and previous examples suggest that blueberry
treatment elicits health benefits through signaling mechanisms
outside, or at least in addition to, antioxidant signaling and
scavenging.
Lowbush cranberry treatment increased lifespan to a lower
extent than blueberry (22% compared to 30–47%), improved
both anterior and posterior touch response late in life, and
only impacted PLM neuron aging (i.e., increased posterior
process branching). Chaga treatment resulted in bimodal lifespan
extension to a similar magnitude as lowbush cranberry (up to
24%), only improved anterior touch response, and both decreased
extended ALM soma outgrowths and increased PLM process
branching and loop events late in life. Interestingly, there is
not a clear relationship between total phenolic, flavonoid, and
anthocyanin contents and these lifespan, healthspan, and neuron
aging results (Table 1), suggesting that the concentrations of these
compounds alone is not enough to predict anti-aging bioactivity.
Although both lowbush cranberry and chaga treatments resulted
in a similar magnitude of lifespan extension, the lowbush
cranberry extract contained nearly 3×, 7×, and 29× more total
phenolic, flavonoid, and anthocyanin content, respectively, than
the chaga extract. Also, the extract containing the highest levels
of all three polyphenols, crowberry, did not extend the lifespan
of wild-type animals at the doses tested. This lack of lifespan
extension may be due to either testing doses with too high
of polyphenolic content or the presence of competing, non-
beneficial molecules in the crowberry extract that are not in the
blueberry or lowbush cranberry extracts.
Chaga extract contained the lowest polyphenol levels of
the studied extracts, yet, endogenous ROS levels of C. elegans
following consumption of chaga extract support previous studies
demonstrating that chaga extracts exert potent antioxidant effects
(Figure 4) (Cui et al., 2005; Giridharan et al., 2011). While
chaga contains polyphenolic compounds (Lee et al., 2007),
the fungus also contains unique non-polyphenolic bioactive
secondary compounds, such as steroid derivatives. Ergosterol
peroxide, a steroid derivative unique to fungi, lichens, yeast,
and sponges, was recently shown to have anti-cancer activity
in a model of colorectal cancer (Kang et al., 2015). The
low polyphenolic content measured in this study’s chaga
extract, when compared to berry extracts coupled with the
observed beneficial effects on aging (e.g., decreased ROS
and increased lifespan), suggests that such a compound may
be central to the health benefits of chaga. The lack of
correlation between the polyphenolic content in these Alaskan
nutraceutical extracts and ROS levels with the observed effects
on whole animal and neuron aging suggests that the general
antioxidant effect (i.e., removal of ROS) by these compounds
may not be central to their involvement in healthy neuron
aging. Rather, chaga-induced healthy neuron aging may be
due to the interaction of polyphenolic and non-polyphenolic
compounds with cellular signaling pathways distinct from
antioxidant signaling pathways, another potential example of
xenohormesis.
Anterior and posterior mechanosensory neurons respond
to aging with different morphological changes: ALM neurons
exhibit increased soma outgrowths and abnormal soma shapes
while PLM neurons exhibit increased process outgrowths with
age (i.e., branching, loops; Pan et al., 2011; Tank et al., 2011;
Toth et al., 2012; Vayndorf et al., 2016). The heterogeneity
in morphological responses to aging between ALM and PLM
neurons may be due to their particular neural networks and,
thus, activity levels. In general terms, the touch receptor neurons
(including the pairs of ALM and PLM neurons) synapse on
interneurons, which then synapse on motor neurons, resulting in
forward or backward movement (reviewed in Goodman, 2006).
As they age, the three anterior touch receptor neurons (ALML,
ALMR, and AVM) form their own neural network via gap
junctions, a characteristic not shared with the posterior touch
receptor neurons (Chalfie et al., 1985). Additionally, only ALM
neurons (not PLM) sensitize to high salt, hypoxia, dauer, and
prolonged vibration, which prevents the animal from repeatedly
changing direction in response to non-localized stressors
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(Chen and Chalfie, 2014). Toth et al. (2012) proposed that the
age-related morphological differences between neurons of the
same class (e.g., PLM and ALM neurons) and between classes of
neurons (e.g., touch receptor versus dopamine neurons) may also
be due to neuronal position (i.e., space to grow) or cell-specific
gene expression. Taken together, the functional differences in the
ALM and PLM neurons likely have consequences for their age-
related morphological changes and, thus, their responses to the
aging process.
We found that both decreased outgrowth from anterior
neuron somas (i.e., soma outgrowths) and increased outgrowth
from posterior neuron axons (i.e., process branching) late
in life are associated with improved mechanosensory neuron
function (i.e., touch response), improved motility, and increased
lifespan (Figure 8). Thus, increased incidence of these age-
related morphologies is not directly correlated with poorer
health: both decreased incidence of ALM aberrations (i.e., soma
outgrowths, abnormal soma shape) and increased incidence of
PLM aberrations (i.e., process branching and loops) correlate
with increased lifespan, improved motility, and improved touch
response. Others have shown that specific genetic mutations
known to be involved in aging (e.g., insulin signaling) seem
to regulate specific mechanosensory neuron morphologies (Pan
et al., 2011; Tank et al., 2011; Toth et al., 2012; Scerbak et al.,
2014). Because of the apparent different cellular controls of these
morphological changes, a synergy in maintaining organismal
health with age may exist between the anterior and posterior
neurons. Aspects of this potential synergy are evident in the
treatment effects of chaga, which impacted both ALM and
PLM neurons: although chaga treatment was not the most
effective at extending lifespan at the doses tested (Figure 1), it
maintained motility the best out of treatments tested (Figure 2)
and maintained anterior touch response better than cranberry
(Figure 3). What remains to be determined is whether increased
incidence of morphological aberrations (e.g., PLM process
branching) is a stimulatory response that actively promotes
healthy aging or whether this phenotype occurs as a consequence
of good health and aging. The ALM and PLM pairs of touch
receptor neurons consistently exhibit differences in their aging
trajectories; reflecting the multifaceted controls of aging at the
cellular level.
CONCLUSION
These data and conclusions also bring up an exciting aspect
of studying the impacts of medicinal foods on aging: the
opportunity to study biological complexities that can rarely
be fully recapitulated by single genetic manipulations. The
varied anti-aging impacts of these medicinal foods on the
nervous system of C. elegans suggest that they may ameliorate
chronic disorder development and progression, such as
neurodegenerative diseases (e.g., Alzheimer’s and Parkinson’s
diseases). Studying the impact of culturally valued foods, such
as Alaskan berries and fungi, not only supports the traditional
ecological knowledge that these foods are beneficial to health, but
provides novel insights into the mechanisms of neuronal aging
and aging in general.
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